Supplemental material
Expert Review of Vaccines
Volume 21, 2022 - Issue 10
Open access
2,912
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children
Josiah Rymana Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Rahway, NJ, USA
https://orcid.org/0000-0002-7692-4432View further author information
Jessica Weaverb Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0002-9861-3328View further author information
Ka Lai Yeea Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Rahway, NJ, USA
https://orcid.org/0000-0003-3099-4440View further author information
Jeffrey R. Sachsa Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Rahway, NJ, USA
https://orcid.org/0000-0001-5725-558XView further author information
Pages 1515-1521
|
Received 08 Jul 2022, Accepted 08 Aug 2022, Published online: 25 Aug 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.